CIK 0001501796 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Aura Biosciences, Inc.
Sign in to watch- Ticker
- AURA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 320271970
- Phone
- (617)500-8864
- Business address
- 80 GUEST STREET, BOSTON, MA, 02135
- 4 Open-market sale Chief Medical Officer sold 2,534 shares at $7.75 ($19,639)
- 4 Open-market sale See Remarks sold 20,221 shares at $7.75 ($156,796)
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 4 Grant or award See Remarks acquired 194,320 shares (grant or award)
- 4 Grant or award Chief Technology Officer acquired 90,475 shares (grant or award)
- 4 Grant or award Chief Medical Officer acquired 120,635 shares (grant or award)
- 4 Grant or award See Remarks acquired 90,475 shares (grant or award)
- 4 Grant or award Senior Vice President, Finance acquired 45,240 shares (grant or award)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 4 Open-market sale See Remarks sold 15,955 shares at $7.67 ($122,381)
- 4 Open-market sale Vice President, Finance sold 1,001 shares at $7.67 ($7,679)
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- 4 Open-market sale Chief Medical Officer sold 11,822 shares at $9.36 ($110,663)
- 144 Insider Sale of Securities
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
- 10-Q Report Quarterly Report
- 8-K Event Results of operations · Other events
Page 8 of 20 · 383 filings